Hanna Kim

机构：University of California, San Francisco · ORCID：0000-0002-0595-6533

发表论文 206 篇 · 总被引 9539 次 · h-index 43

代表论文

• CAR T cell therapy for children with rheumatic disease: the time is now (2025 · Nature Reviews Rheumatology · 被引 13)
• Monoclonal antibody targeting IFNβ for the treatment of NXP2-positive ulcerative juvenile dermatomyositis (2025 · PEDIATRICS · 被引 5)
• Updates in juvenile dermatomyositis: pathogenesis and therapy (2025 · Current Opinion in Rheumatology · 被引 4)
• Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype (2025 · Annals of the Rheumatic Diseases · 被引 2)
• Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplant (2025 · JCI Insight · 被引 2)
• Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies (2024 · Journal of Investigative Dermatology · 被引 2)